Selected Publications
Vargas SH, Kossatz S, Voss J, Ghosh SC, Cao HST, Simien J, Reiner T, Dhingra S, Fisher WE, Azhdarinia A, 2019. Specific targeting of somatostatin receptor subtype-2 for fluorescence-guided surgery. Clinical Cancer Research, 2019, pp.clincanres-3312 [Epub ahead of print] PMID: 31015345
Kossatz S*, Carney B, Farley C, Drain CM, Weber WA, Reiner T. Direct imaging of drug distribution and target engagement of the PARP inhibitor rucaparib. Journal of Nuclear Medicine, 2018, 59 (8), 1316-1320. *corresponding author. PMID: 29572258.
Jannetti, SA, Carlucci G, Carney B, Kossatz S, Shenker L, Salinas B, Brand C, Sadique A, Donabedian PL, Cunanan KM, Gonen M, Ponomarev V, Zeglis BM, Souweidane MM, Lewis JS, Weber WA, Humm JL, Reiner T. PARP1-targeted radiotherapy in mouse models of glioblastoma. Journal of Nuclear Medicine, 2018, 59 (8), 1225-1233. PMID: 29572254.
Carney B, Kossatz S, Lok BH, Schneeberger V, Gangangari KK, Pillarsetty N, Weber WA, Rudin CM, Poirier JT, Reiner T. Target Engagement Imaging of PARP Inhibitors in Small Cell Lung Cancer. Nature Communications, 2018, Jan 12;9(1):176. PMID: 29330466.
Tang J, Salloum D, Carney B, Brand C, Kossatz S, Sadique A, Weber WA, Wendel HG, Reiner T. A Targeted PET Imaging Strategy to Differentiate Malignant from Inflamed Lymph Nodes in Diffuse Large B-Cell Lymphoma. Proceedings of the National Academy of Sciences, 2017, 201705013. PMID: 28827325.
Kossatz S, Carney B, Schweitzer ME, Carlucci G, Miloushev V, Maachani UB, Rajappa P, Keshari KR, Pisapia D, Weber WA, Souweidane MM, Reiner T. Biomarker based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models. Cancer Research, 2017, 77.8: 2112-2123. PMID: 28108511.
Kossatz S, Brand C, Gutiontov S, Liu JTC, Lee N, Gonen M, Weber WA, Reiner T. Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent. Nature Scientific Reports, 2016, 21371. PMID: 26900125.
Kossatz S, Weber AW, Reiner T. Optical Imaging of PARP1 in response to radiation in Oral Squamous Cell Carcinoma. PloS one, 2016, 11.1: e0147752. PMID: 26808835.
Kossatz S, Grandke J, Couleaud P, Latorre A, Aires A, Crosbie-Staunton K, Ludwig R, Daehring H, Ettelt V, Lazaro-Carrillo A, Calero M, Sader M, Courty J, Volkov Y, Prina-Mello A, Villanueva A, Somoza A, Cortajareno AL, Miranda R, Hilger I. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Research, 2015, 17(1), 66. PMID: 25968050.
Kossatz S*, Ludwig R*, Dähring H, Ettelt V, Rimkus G, Marciello M, Salas G, Patel V, Teran FJ, Hilger I. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area. Pharmaceutical Research, 2014, 31(12), 3274–88. *contributed equally PMID: 24890197.
Kossatz S, Béhé M, Mansi R, Czerney P, Kaiser WA, Hilger I. Multifactorial diagnostic imaging of CCK2R expressing tumors. Biomaterials, 2013, 34(21): 5172–5180. PMID: 23591397.
A full list of publications can be found here: https://www.ncbi.nlm.nih.gov/pubmed/?term=susanne+kossatz